Laboratory and Diagnostic Testing in Acute Pancreatitis
Initial Laboratory Panel at Admission
All patients presenting with acute pancreatitis should have the following serum tests obtained immediately at admission: amylase or lipase, triglycerides, calcium, and liver chemistries (bilirubin, AST, ALT, alkaline phosphatase). 1
Diagnostic Confirmation
- Serum lipase is the preferred diagnostic test over amylase, with a diagnostic threshold of ≥3 times the upper limit of normal, offering superior sensitivity (79-89%) and specificity (89-94%) 2
- Lipase remains elevated for 8-14 days compared to amylase's shorter window, making it more reliable for delayed presentations 2
- Ordering both lipase and amylase together provides no diagnostic advantage 2
Etiological Determination
Liver Function Tests:
- Elevated AST, ALT, bilirubin, or alkaline phosphatase at admission strongly suggests gallstone etiology 1
- Early aminotransferase elevation is particularly predictive of biliary pancreatitis 1
Triglyceride Measurement:
- Critical to measure at admission because levels drop rapidly with fasting and IV fluids 3
- Triglyceride levels ≥1000 mg/dL definitively indicate hypertriglyceridemia-induced pancreatitis 3, 4
- Levels between 500-1000 mg/dL with lactescent serum should raise high suspicion, especially without other clear etiology 4
- If initial triglycerides are <1000 mg/dL but suspicion remains, measure fasting triglycerides after recovery 1
Calcium Level:
- Measure at admission to identify hypercalcemia as a potential cause 1, 2
- Hypercalcemia is less common but important not to miss 3
Severity Assessment Laboratory Tests
C-Reactive Protein (CRP):
- CRP ≥150 mg/L at 48-72 hours after symptom onset is the preferred laboratory marker for predicting severe disease 1, 5
- Sensitivity 38-61%, specificity 89-90% 5
- Major limitation: cannot be used for immediate severity assessment at presentation as peak levels only occur at 48-72 hours 5
Additional Severity Markers:
- Complete blood count for hematocrit and white blood cell count 2
- BUN and creatinine for renal function assessment 5
- Glucose and electrolytes for metabolic abnormalities 1
Clinical Scoring Systems:
- APACHE II score should be calculated, with a cutoff of >8 indicating predicted severe disease requiring intensive monitoring 1
- Multiple factor scoring systems are preferred over single laboratory values 1
Imaging Studies
Abdominal Ultrasonography:
- Should be obtained at admission in all patients to evaluate for cholelithiasis or choledocholithiasis 1
- If initial ultrasound is inadequate or gallstone suspicion persists, repeat after recovery 1
- Endoscopic ultrasound (EUS) can serve as an accurate alternative for screening gallstones 1
Contrast-Enhanced CT Scanning:
- Perform after 72 hours of illness in patients with predicted severe disease (APACHE II >8) or evidence of organ failure to assess pancreatic necrosis 1
- Use selectively based on clinical features in patients not meeting these criteria 1
- Not routinely needed in mild predicted cases unless clinical deterioration occurs 1
Special Circumstances
Unexplained Pancreatitis in Patients >40 Years:
- CT or EUS should be performed to exclude underlying pancreatic malignancy 1
Recurrent Pancreatitis:
- Consider EUS and/or ERCP, with EUS preferred as initial test 1
- ERCP should only be performed by experienced endoscopists with therapeutic capabilities 1
Autoimmune Pancreatitis Suspicion:
- Serum IgG4 level should be ordered, with >280 mg/dL being diagnostic for type 1 autoimmune pancreatitis 2
Common Pitfalls to Avoid
- Do not delay triglyceride measurement - levels normalize rapidly with treatment, potentially missing hypertriglyceridemia as the etiology 3
- Do not order routine CT at admission - wait 72 hours unless diagnostic uncertainty exists, as early CT underestimates necrosis 1
- Do not rely solely on CRP at admission - it requires 48-72 hours to reach diagnostic levels for severity prediction 5
- The etiology should be established in at least 75-80% of cases; more than 20-25% classified as "idiopathic" suggests inadequate workup 1